Phibro Animal Health (PAHC) Cash from Investing Activities Growth (1y) (2014 - 2026)
Phibro Animal Health (PAHC) Cash from Investing Activities Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 13.93% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 57.14% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -186.78% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 551.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 526.11% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -3,664.79% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -3.45% |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn | 7.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.92% |
| Dec 31, 2025 | 93.40% |
| Sep 30, 2025 | -617.20% |
| Jun 30, 2025 | 22.80% |
| Mar 31, 2025 | -1,715.13% |
| Dec 31, 2024 | -947.72% |
| Sep 30, 2024 | 80.91% |
| Jun 30, 2024 | 11.39% |
| Mar 31, 2024 | 102.99% |
| Dec 31, 2023 | -153.43% |
| Sep 30, 2023 | 4.94% |
| Jun 30, 2023 | -7.78% |
| Mar 31, 2023 | -279.90% |
| Dec 31, 2022 | -155.84% |
| Sep 30, 2022 | 21.86% |
| Jun 30, 2022 | -32.68% |
| Mar 31, 2022 | -200.76% |
| Dec 31, 2021 | 330.43% |
| Sep 30, 2021 | -51.57% |
| Jun 30, 2021 | 24.58% |